We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
Cap. Flow
-$1.18B
Cap. Flow %
-0.95%
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$80.1M
2
CVX icon
Chevron
CVX
+$75.4M
3
HOOD icon
Robinhood
HOOD
+$52.2M
4
NTNX icon
Nutanix
NTNX
+$32.2M
5
DDOG icon
Datadog
DDOG
+$29.9M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$166M
2
AAPL icon
Apple
AAPL
+$150M
3
NVDA icon
NVIDIA
NVDA
+$148M
4
HES
Hess
HES
+$72.3M
5
ANSS
Ansys
ANSS
+$59M

Sector Composition

Rank Sector Weight
1 Technology 32.89%
2 Financials 13.4%
3 Consumer Discretionary 10.96%
4 Communication Services 9.45%
5 Healthcare 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBC
3351
SBC Medical Group
SBC
$314M
$28.1K ﹤0.01%
6,478
-3,167
-33% -$14.3K
NXXT
3352
NextNRG Inc
NXXT
$48.8M
$27.5K ﹤0.01%
15,009
-2,473
-14% -$4.33K
AUTL
3353
Autolus Therapeutics
AUTL
$562M
$26.7K ﹤0.01%
16,381
-328
-2% -$641
VRM icon
3354
Vroom Inc
VRM
$48.2M
$26.2K ﹤0.01%
971
-109
-10% -$3K
VEON icon
3355
VEON
VEON
$3.95B
$25.7K ﹤0.01%
473
-60
-11% -$3.22K
BCYC
3356
Bicycle Therapeutics
BCYC
$292M
$25.3K ﹤0.01%
3,275
+270
+9% +$2.04K
XNET
3357
Xunlei
XNET
$326M
$25.3K ﹤0.01%
2,642
-10,660
-80% -$65.6K
CMMB
3358
Chemomab Therapeutics
CMMB
$14.1M
$25K ﹤0.01%
9,505
-464
-5% -$1.71K
TLX
3359
Telix Pharmaceuticals
TLX
$3.9B
$24.7K ﹤0.01%
2,579
+1,392
+117% +$17.1K
LUCK
3360
Lucky Strike Entertainment
LUCK
$911M
$24.2K ﹤0.01%
2,367
EH
3361
EHang Holdings
EH
$435M
$24.2K ﹤0.01%
1,303
-340
-21% -$5.95K
GOTU icon
3362
Gaotu Techedu
GOTU
$436M
$24.2K ﹤0.01%
7,410
-480
-6% -$1.74K
ZTO icon
3363
ZTO Express
ZTO
$17.9B
$24.1K ﹤0.01%
1,255
-1,158
-48% -$22.2K
MYO icon
3364
Myomo
MYO
$56.2M
$24K ﹤0.01%
26,920
-3,014
-10% -$4.39K
TRVG
3365
trivago
TRVG
$397M
$23.9K ﹤0.01%
7,175
-282
-4% -$1K
SVRE
3366
SaverOne 2014 Ltd
SVRE
$6.15M
$23.6K ﹤0.01%
1,199
+834
+228% +$20.4K
COE
3367
51Talk Online Education Group
COE
$117M
$23K ﹤0.01%
519
+73
+16% +$2.63K
TLRY icon
3368
Tilray
TLRY
$622M
$22.7K ﹤0.01%
1,311
CV
3369
CapsoVision Inc
CV
$355M
$22.4K ﹤0.01%
+4,630
New +$19.4K
ASAI
3370
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$21.9K ﹤0.01%
2,545
-2,121
-45% -$18.2K
AMRN
3371
Amarin Corp
AMRN
$303M
$21.6K ﹤0.01%
1,320
+58
+5% +$901
CMPS
3372
Compass Pathways
CMPS
$1.83B
$21.6K ﹤0.01%
3,768
+40
+1% +$180
HHR
3373
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$21.5K ﹤0.01%
1,430
CSAN icon
3374
Cosan
CSAN
$2.84B
$21.5K ﹤0.01%
4,672
-100
-2% -$462
NOMD icon
3375
Nomad Foods
NOMD
$1.68B
$21.5K ﹤0.01%
1,633
-301
-16% -$4.71K

Similar funds

RhumbLine Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
  • RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
  • RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
  • RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
  • RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
  • RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
  • RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.

Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.